Insider Trading & Ownership - abrdn Life Sciences Investors (HQL)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for abrdn Life Sciences Investors
Goto Prev, 0, 1
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-01
Purchase
2024-05-02
4:50 pm
abrdn Life Sciences Investors HQL Saba Capital Management L.P.
Weinstein Boaz
10% Owner
26,526 $13.46 $356,929 3,068,730
(Indirect)
View
2024-04-30
Purchase
2024-05-01
10:23 am
abrdn Life Sciences Investors HQL Saba Capital Management L.P.
Weinstein Boaz
10% Owner
16,573 $13.13 $217,603 3,042,204
(Indirect)
View
2024-04-26
Purchase
2024-04-29
4:54 pm
abrdn Life Sciences Investors HQL Saba Capital Management L.P.
Weinstein Boaz
10% Owner
120,304 $13 $1,563,952 3,025,602
(Indirect)
View
2024-04-24
Purchase
2024-04-26
11:40 am
abrdn Life Sciences Investors HQL Saba Capital Management L.P.
Weinstein Boaz
10% Owner
118,103 $13.01 $1,536,827 2,905,298
(Indirect)
View
2024-04-22
Purchase
2024-04-23
8:00 pm
abrdn Life Sciences Investors HQL Saba Capital Management L.P.
Weinstein Boaz
10% Owner
50,225 $13.14 $659,913 2,787,195
(Indirect)
View
2024-04-18
Purchase
2024-04-22
3:08 pm
abrdn Life Sciences Investors HQL Saba Capital Management L.P.
Weinstein Boaz
10% Owner
124,197 $12.81 $1,591,420 2,736,970
(Indirect)
View
2024-04-09
Purchase
2024-04-12
09:20 am
abrdn Life Sciences Investors HQL Goetz Kathleen
Director
400 $13.32 $5,327 1,085
(Direct)
View
2024-01-02
Purchase
2024-01-04
2:23 pm
abrdn Life Sciences Investors HQL Reit Todd
Director
1,000 $13.8 $13,798 1,000
(Direct)
View
2023-12-28
Purchase
2024-01-02
4:34 pm
abrdn Life Sciences Investors HQL Maher Bill
Director
1,000 $13.57 $13,570 1,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2024-04-19
08:05 am
N/A
N/A
abrdn Life Sciences Investors HQL Saba Capital Management L.P.
Weinstein Boaz
10% Owner
0 $0 2,694,511
(Indirect)
View
Goto Prev, 0, 1